Back to search
FDAFDA · Food and drugs·Recall number D-0925-2018

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

Published July 18, 2018 · Recall initiated: July 5, 2018

Summary

FDA records drug Class II recall D-0925-2018, published July 18, 2018 and initiated July 5, 2018. Recalling firm: Sanofi-Aventis U.S. LLC; Status: Ongoing; Reported quantity: 3214 prefilled pens; Lot: Lot #: 7F021B, Exp 6/30/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

What to do

Voluntary: Firm initiated · Letter

Get an email if ADMELOG has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ADMELOG
Manufacturer
Sanofi-Aventis U.S. LLC
Distributor
Nationwide
Lot
Lot #: 7F021B, Exp 6/30/20
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00 recalled?

Yes. FDA published recall D-0925-2018 on July 18, 2018. Reported hazard: Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ADMELOG.